Возраст домена | 15 лет |
Дата окончания | Истек срок регистрации |
ИКС | n/a |
Страниц в Google | 2 |
Страниц в Яндексе | 1 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 13175699 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Optimize drug value | Drug and device commercialisation & outcomes
n/a
ICON Commercialisation & Outcomes delivers resources and expertise to identify, generate, synthesize and communicate evidence of treatment value and safety.
UTF-8
51.7 КБ
1 005
8 266 симв.
7 138 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
medimedia.com | 6 | 4 |
0 | 2772657 | 742229 | |
simplyhired.com | 4 | 7 |
0 | 8694 | 1923 | |
glassdoor.com | 4 | 7 |
0 | 408 | 96 | |
yellowpages.com | 2 | 7 |
0 | 4520 | 864 | |
manta.com | 2 | 6 |
0 | 5436 | 1230 | |
indeed.com | 2 | 8 |
0 | 138 | 50 | |
veeva.com | 2 | 5 |
10 | 151628 | 51333 | |
pharmainstitute.com | 2 | 4 |
0 | 2300315 | Нет данных | |
mmm-online.com | 2 | 5 |
10 | 222016 | 46697 | |
cbinet.com | 1 | 5 |
0 | 262070 | 69476 | |
Еще 34 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 14 Мая 2014 ) | |
Количество ссылок на сайт | 6 |
Количество доменов, которые ссылаются на сайт | 5 |
Количество найденных анкоров | 5 |
Исходящие (внешние) ссылки домена | 4 |
Количество доменов, на которые ссылается сайт | 4 |
Количество исходящих анкоров | 3 |
Внешние ссылки главной страницы ( 15 ) | |
webinars.iconplc.com/ | On-Demand Webinars Visit the Webinar Channel |
hematology.org/Annual-Meeting/ | ASH Annual Meeting 7 - 10 December, 2019 |
careers.iconplc.com/ | Jobs & Careers |
investor.iconplc.com/ | Investors |
iconplc.com/services/clinical-research-services/site-and-pat... | Patients |
iconplc.com/services/commercialisation-and-outcomes/language... | Language Services As the industry’s largest life sciences language services provider, we deliver translations, linguistic valida... |
iconplc.com/services/commercialisation-and-outcomes/briefing | Subscribe to our newsletter to receive future issues of our briefing |
www2.iconplc.com/commercialisation_briefing_June2019 | Latest Briefing: ‘Medicare for All’ and the Implications for US Market Access Download our latest issue to explore insights, in... |
investor.iconplc.com/financials-filings/annual-reports | Results & Reports |
iconplc.com/study-volunteers | Volunteers |
investor.iconplc.com/ | Investors |
linkedin.com/company/icon-plc-2 | |
twitter.com/ICONplc | |
facebook.com/icon.plc.profile | |
youtube.com/user/ICONPlc | Youtube |
Внутренние ссылки главной страницы ( 89 ) | |
# | - |
/services/ | Services |
/services/adaptive-trials/ | Adaptive Trials |
/services/clinical-research-services/ | Clinical Research Services Integrated services that cover planning, management, execution and analysis. |
/services/commercialisation-and-outcomes/ | Commercialisation & Outcomes |
/services/consulting/ | Consulting |
/services/early-phase/ | Early Phase |
/services/functional-services-provision/ | Functional Services Provision |
/services/laboratories/ | Laboratories |
/services/imaging/ | Medical Imaging |
/services/clinical-research-services/site-and-patient-recrui... | Site & Patient Solutions Site and patient identification, enrolment and engagement. |
/sectors/ | Sectors |
/sectors/biosimilars/ | Biosimilars |
/sectors/biotech/ | Biotech |
/sectors/government-and-public-health-solutions/ | Government & Public Health Solutions |
/sectors/medical-device/ | Medical Device |
/sectors/pharma/ | Pharmaceuticals |
/sectors/medical-device/regulatory-affairs/eu-regulations_md... | EU MDR/IVDR Regulations The new EU medical and in vitro diagnostic device regulations go into effect at the start of 2020. Are y... |
/insights/value-based-healthcare/making-sense-of-the-biosimi... | Making sense of the Biosimilars market Strategies and recommendations to achieve optimal market access. |
/therapeutics/ | Therapeutics |
/therapeutics/cardiovascular/ | Cardiovascular |
/therapeutics/central-nervous-system/ | Central Nervous System |
/therapeutics/endocrine-metabolic-disorders/ | Endocrine & Metabolic Disorders |
/therapeutics/genomics/ | Genomics |
/therapeutics/infectious-diseases/ | Infectious Diseases |
/therapeutics/internal-medicine-and-immunology/ | Internal Medicine & Immunology |
/therapeutics/medical-device/ | Medical Device |
/therapeutics/ophthalmology/ | Ophthalmology |
/therapeutics/rare-and-orphan-diseases/ | Rare & Orphan Diseases |
/therapeutics/transplant-immunology/ | Transplant Immunology |
/therapeutics/womens-health/ | Women's Health |
/therapeutics/oncology/ | Oncology ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR... |
/therapeutics/vaccines/ | Vaccines ICON has recently led the development of 14 vaccines resulting in FDA/EMA approvals. |
/innovation/ | Innovation |
/innovation/firecrest/ | FIRECREST |
/innovation/Intel-Pharma-Analytics/ | Intel Pharma Analytics Platform |
/innovation/drug-safety-reporting-solution/ | Drug Safety Reporting Solution |
/innovation/one-search/ | One Search |
/innovation/evidence-platform/ | Evidence Platform |
/innovation/flex-advantage/ | FLEX ADVANTAGE |
/innovation/imaging-technology/ | Medical Imaging Technology |
/innovation/nonmem/ | NONMEM |
/innovation/ICONIK/ | ICONIK |
/innovation/pdx-pop/ | PDx-POP |
/innovation/imra/ | IMRA |
/innovation/pubshub/ | PubsHub |
/innovation/addplan/ | ADDPLAN® Using data to design, simulate, and analyse adaptive clinical trials with ease. |
/innovation/patient-engagement-platform/ | Patient Engagement Portal Connecting patients with the right trial in the right location. |
/insights/ | Insights |
/insights/digital-disruption/ | Digital Disruption |
/insights/patient-centricity/ | Patient Centricity |
/insights/transforming-trials/ | Transforming Trials |
/insights/value-based-healthcare/ | Value Based Healthcare |
/insights/blog/ | Blog |
/insights/videos/ | Videos |
/insights/digital-disruption/mHealth-wearables/ | mHealth & Wearables Remote monitoring and leveraging wearable devices and sensors in clinical trials. |
/insights/digital-disruption/real-world-data/ | Real World Data Reduce post market study costs with Real World Data. |
/news-events/ | News & Events |
/news-events/press-releases/ | Press Releases |
/news-events/thought-leadership/ | In the News |
/news-events/events/ | Events |
/news-events/mediakit/ | Mediakit |
/news-events/social-media/ | ICON on social media |
/news-events/awards/ | Awards |
/about/ | About ICON |
/about/company-history/ | Company History |
/about/icon-in-asia-pacific/ | ICON in Asia Pacific |
/about/icon-in-latin-america/ | ICON in Latin America |
/about/leadership/executive-management/ | Leadership |
/about/our-quality/ | Quality We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities. |
/about/icon-and-you/ | ICON and You Partners Making a Difference. |
/investigators/ | Investigators |
/contact/ | Contact us |
index.xml?&Language=en | EN |
index.xml?&Language=ja | 日本語 |
/services/commercialisation-and-outcomes/rwe-late-phase-rese... | Real World Evidence and Late Phase Research Correct study choice and effective execution are paramount to achieving your goals.... |
/services/commercialisation-and-outcomes/commercialisation-c... | Access, Commercialisation and Communications Our integrated team of 300+ industry experts provides life-science clients with st... |
/services/commercialisation-and-outcomes/patient-centred-sci... | Patient Centred Sciences Patients are at the heart of our research. We help pharma, device and biotechnology companies at every... |
/services/commercialisation-and-outcomes/real-world-intellig... | Real World Evidence Strategy and Analytics Our global epidemiologists and outcomes researchers employ Real World Intelligence, c... |
/services/commercialisation-and-outcomes/patient-and-site-en... | Late Phase Patient and Site Engagement We understand the unique requirements of managing late phase and post-market studies. Our... |
/services/commercialisation-and-outcomes/strategic-regulator... | Strategic Regulatory Services Today’s regulatory landscape is complex and ever-changing. We deliver solutions built on 30+ years... |
/services/commercialisation-and-outcomes/mapi-research-trust... | Mapi Research Trust ICON is the leading sponsor of Mapi Research Trust, a non-profit organisation dedicated to improving patient... |
/services/commercialisation-and-outcomes/briefing/index.xml | Briefing Commercialisation & Outcomes Briefing |
/disclaimer/ | Disclaimer |
/privacy/ | Privacy |
/site-cookies/ | Site Cookies |
/contact/submit-rfp/ | Submit proposal request |
/preferences/ | Update Email Preferences |
/contact/global-office-locator/ | Global office locator |
Domain Name: MEDIMEDIAMANAGEDMARKETS.COM
Registry Domain ID:
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2013-11-14T00:00:00Z
Creation Date: 2008-09-11T00:00:00Z
Registrar Registration Expiration Date: 2015-09-11T00:00:00Z
Registrar: NETWORK SOLUTIONS, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Reseller:
Domain Status: clientTransferProhibited
Registry Registrant ID:
Registrant Name: CHC/MMMM
Registrant Organization: CHC/MMMM
Registrant Street: 780 Township Line Road
Registrant City: Yardley
Registrant State/Province: PA
Registrant Postal Code: 19067
Registrant Country: US
Registrant Phone: 267-685-2328
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: svassallo@medimedia.com
Registry Admin ID:
Admin Name: CHC/MMMM
Admin Organization: CHC/MMMM
Admin Street: 780 Township Line Road
Admin City: Yardley
Admin State/Province: PA
Admin Postal Code: 19067
Admin Country: US
Admin Phone: 267-685-2328
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: svassallo@medimedia.com
Registry Tech ID:
Tech Name: CHC/MMMM
Tech Organization: CHC/MMMM
Tech Street: 780 Township Line Road
Tech City: Yardley
Tech State/Province: PA
Tech Postal Code: 19067
Tech Country: US
Tech Phone: 267-685-2328
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: svassallo@medimedia.com
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
>>> Last update of whois database: Wed, 09 Jul 2014 18:04:52 UTC <<<
США - 67.98.26.80
Level 3 Communications
Level 3 Communications
HTTP/1.1 200 OK
Accept-Ranges: bytes
Cache-control: no-cache="set-cookie"
Content-Type: text/html; charset=UTF-8
Date: Tue, 03 Dec 2019 14:22:10 GMT
ETag: "75f8b3a89af8461bcd299a25d29a1cd4"
Expires: Mon, 03 Dec 2018 08:22:10 GMT
Last-Modified: Tue, 03 Dec 2019 14:22:10 GMT
Server: Roxen
Set-Cookie: AWSELB=CB9DA3E70E32836717257EE63CF891E0239CAB8B07A3554C7CF4E3DFE2784815B0166488A92B6C62D5EB8AF58D0624109D42EC6E1F60FFDCE7058A7E290DF4186ECF83B183;PATH=/
Vary: *
X-Frame-Options: deny
X-XSS-Protection: 1; mode = block
Content-Length: 52939
Connection: keep-alive
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"